| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | CONFOMRTRX INC | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44MH112215 | Structure-based discovery of dopamine D1 receptor selective small molecule ligands | 000 | 5 | NIH | 2/16/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $601,688 ) |
| | 2023 | 2023 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R43DK136454 | Discovery of GPR75 small molecule ligands for the treatment of obesity | 000 | 1 | NIH | 7/17/2023 | $303,375 |
| | 2023 | 2023 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R43NS130717 | Discovery of GPR171 small molecule ligands for the treatment of chronic pain | 000 | 1 | NIH | 9/18/2023 | $298,313 |
| | 2023 | 2021 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44MH112215 | Structure-based discovery of dopamine D1 receptor selective small molecule ligands | 000 | 5 | NIH | 12/16/2022 | $0 |
| | 2023 | 2021 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44MH115875 | Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands | 000 | 4 | NIH | 7/15/2023 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,414,181 ) |
| | 2021 | 2021 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44MH115875 | Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands | 000 | 4 | NIH | 6/24/2021 | $738,119 |
| | 2021 | 2021 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44MH112215 | Structure-based discovery of dopamine D1 receptor selective small molecule ligands | 000 | 5 | NIH | 12/17/2020 | $676,062 |
|
| Issue Date FY: 2020 ( Subtotal = $1,440,593 ) |
| | 2020 | 2020 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44MH115875 | Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands | 000 | 3 | NIH | 7/7/2020 | $764,531 |
| | 2020 | 2020 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44MH112215 | Structure-based discovery of dopamine D1 receptor selective small molecule ligands | 000 | 4 | NIH | 12/20/2019 | $676,062 |
|
| Issue Date FY: 2019 ( Subtotal = $1,335,245 ) |
| | 2019 | 2019 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44MH112215 | Structure-based discovery of dopamine D1 receptor selective small molecule ligands | 000 | 3 | NIH | 1/4/2019 | $676,062 |
| | 2019 | 2019 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44MH115875 | Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands | 000 | 2 | NIH | 7/18/2019 | $659,183 |
| | 2019 | 2017 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44DK106942 | Structure-based Drug Discovery for the GLP-1 Receptor | 000 | 3 | NIH | 12/4/2018 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $381,468 ) |
| | 2018 | 2018 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44MH112215 | Structure-based discovery of dopamine D1 receptor selective small molecule ligands | 000 | 2 | NIH | 12/7/2017 | $381,468 |
| | 2018 | 2017 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R43MH115875 | Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands | 000 | 1 | NIH | 8/28/2018 | $0 |
| | 2018 | 2015 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44DK106942 | Structure-based Drug Discovery for the GLP-1 Receptor | 000 | 1 | NIH | 8/8/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $1,064,491 ) |
| | 2017 | 2017 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44DK106942 | Structure-based Drug Discovery for the GLP-1 Receptor | 000 | 3 | NIH | 9/12/2017 | $494,338 |
| | 2017 | 2017 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R43MH115875 | Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands | 000 | 1 | NIH | 7/1/2017 | $193,685 |
| | 2017 | 2017 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44MH112215 | Structure-based discovery of dopamine D1 receptor selective small molecule ligands | 000 | 1 | NIH | 12/27/2016 | $376,468 |
| | 2017 | 2017 | CONFOMETRX | 840 CHIMALUS DR | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44MH112215 | Structure-based discovery of dopamine D1 receptor selective small molecule ligands | 001 | 1 | NIH | 12/31/2016 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $467,338 ) |
| | 2016 | 2016 | CONFOMETRX INC | 840 CHIMALUS DRIVE | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44DK106942 | Structure-based Drug Discovery for the GLP-1 Receptor | 000 | 2 | NIH | 7/22/2016 | $467,338 |
|
| Issue Date FY: 2015 ( Subtotal = $249,003 ) |
| | 2015 | 2015 | CONFOMETRX INC | 840 CHIMALUS DRIVE | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44DK106942 | Structure-based Drug Discovery for the GLP-1 Receptor | 000 | 1 | NIH | 7/24/2015 | $249,003 |
|
| Issue Date FY: 2014 ( Subtotal = $333,000 ) |
| | 2014 | 2014 | CONFOMETRX INC | 840 CHIMALUS DRIVE | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44MH088091 | DEVELOPING METHODS FOR CRYSTALLIZING FAMILY C GPCRS | 000 | 5 | NIH | 7/26/2014 | $333,000 |
|
| Issue Date FY: 2013 ( Subtotal = $333,000 ) |
| | 2013 | 2013 | CONFOMETRX INC | 840 CHIMALUS DRIVE | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44MH088091 | DEVELOPING METHODS FOR CRYSTALLIZING FAMILY C GPCRS | 000 | 4 | NIH | 9/3/2013 | $333,000 |
|
| Issue Date FY: 2012 ( Subtotal = $333,000 ) |
| | 2012 | 2012 | CONFOMETRX INC | 840 CHIMALUS DRIVE | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R44MH088091 | DEVELOPING METHODS FOR CRYSTALLIZING FAMILY C GPCRS | 000 | 3 | NIH | 8/10/2012 | $333,000 |
|
| Issue Date FY: 2011 ( Subtotal = $250,000 ) |
| | 2011 | 2011 | CONFOMETRX INC | 840 CHIMALUS DRIVE | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R43MH088091 | DEVELOPING METHODS FOR CRYSTALLIZING FAMILY C GPCRS | 000 | 2 | NIH | 12/3/2010 | $250,000 |
|
| Issue Date FY: 2010 ( Subtotal = $250,000 ) |
| | 2010 | 2010 | CONFOMETRX INC | 840 CHIMALUS DRIVE | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R43MH088091 | DEVELOPING METHODS FOR CRYSTALLIZING FAMILY C GPCRS | 000 | 1 | NIH | 2/8/2010 | $250,000 |
|
| Issue Date FY: 2009 ( Subtotal = $100,000 ) |
| | 2009 | 2009 | CONFOMETRX INC | 840 CHIMALUS DRIVE | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R43GM088950 | DEVELOPING METHODS FOR CRYSTALLIZING CLASS B GPCRS | 001 | 1 | NIH | 7/30/2009 | -$100,000 |
| | 2009 | 2009 | CONFOMETRX INC | 840 CHIMALUS DRIVE | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R43GM088950 | DEVELOPING METHODS FOR CRYSTALLIZING CLASS B GPCRS | 001 | 1 | NIH | 7/30/2009 | $100,000 |
| | 2009 | 2009 | CONFOMETRX INC | 840 CHIMALUS DRIVE | PALO ALTO | CA | 94306-2602 | SANTA CLARA | USA | R43GM088950 | DEVELOPING METHODS FOR CRYSTALLIZING CLASS B GPCRS | 000 | 1 | NIH | 7/27/2009 | $100,000 |
|
| Issue Date FY: 2006 ( Subtotal = $100,000 ) |
| | 2006 | 2006 | CONFOMETRX INC | 840 CHIMALUS DRIVE | PALO ALTO | CA | 94306 | SANTA CLARA | USA | R43GM076845 | FLUORESCENT G PROTEINS FOR GPCR DRUG DISCOVERY | 000 | 1 | NIH | 3/10/2006 | $100,000 |
|
|
